Eculizumab Administration and Immunization Insights in Neuromyelitis Optica

This chapter explores the administration of eculizumab for patients with Neuromyelitis Optica Spectrum Disorders, highlighting the role of prior treatments like rituximab on vaccination responses. It also discusses the logistical considerations of treatment and introduces Ravulizumab as a potentially advantageous alternative with less frequent dosing.